Category Archives: Generic drug

India rejects Gilead’s Hepatitis C drug patent request

Source: Reuters 15 Jan 2015 (Reuters) – India’s patent office has rejected an application from U.S.-based Gilead Sciences Inc for its hepatitis C drug Sovaldi, paving the way for local drugmakers to launch cheaper generic versions of the $1,000-a-pill medicine. … Continue reading

Posted in access to medicines, Generic drug, Hepatitis - C, Indian Patent Law, patent, Sofosbuvir | Tagged , , , | Leave a comment

For First Time, F.D.A. Panel Approves Generic Copy of Costly Biologic Drug

Source: New York Times 9 Jan 2015 SILVER SPRING, Md. — An expert panel unanimously recommended on Wednesday that the Food and Drug Administration approve a cheaper copy of a special drug used in cancer therapy, paving the way for … Continue reading

Posted in Biologics, biosimilars, Generic drug, patent | Leave a comment

Going large

Source: The Economist 6 Jan 2015 A wave of new medicines known as biologics will be good for drugmakers, but may not be so good for health budgets IN PHARMACEUTICALS, the 20th century was the era of the small molecule. … Continue reading

Posted in Biologics, biosimilars, Generic drug, patent, USFDA | Leave a comment

Leukemia Patient in Court for Buying Cheap Medicine from India

Source: Caixin Online Lu Yong nearly went broke getting his drugs in China, but purchasing a cheap generic substitute from abroad has landed him in legal trouble (Beijing) – To prosecutors, a leukemia patient named Lu Yong is a criminal … Continue reading

Posted in access to medicines, Counterfeit, Generic drug | Leave a comment

Bayer’s Indian appeal fails to block drug

Source: Trading Room DPA 15th December 2014 India’s Supreme Court has rejected German drug manufacturer Bayer AG’s plea to block production of a cheaper generic version of a patented cancer drug, in a ruling that ensures the medicine will be … Continue reading

Posted in access to medicines, Cancer, Compulsory Licensing, Drug Pricing, Generic drug | Leave a comment

Generic drug makers get a boost from SC ruling

Source: Hindu 14th December 2014 The Research and Development Centre of Natco Pharma, in Hyderabad. In a significant development for the pharmaceutical industry, the Supreme Court has rejected multinational Bayer’s appeal to block production and sales of the low cost … Continue reading

Posted in access to medicines, Cancer, Compulsory Licensing, Drug quality, Generic drug | Leave a comment

Let India Make Cheap Drugs

Source: NY Times NEW HAVEN, Conn. — Last month, the United States and India announced an important breakthrough concerning India’s “right-to-food” program. The Indian government subsidizes food for its poorest citizens through a system of price supports and public stockpiling. The … Continue reading

Posted in access to medicines, Drug Pricing, Generic drug, HIV/Aids, Intellectual Property, IP Rights, patent, Right to Health, WTO | Leave a comment